Coming into 2014, Biotech China has gathered more than 300 exhibitors
and received about 1,500 online visitor registrations from 12 countries
and regions. Especially for the popular overseas pavilions, they have
attracted companies from more than 12 nations, including 4 national
pavilions from Israel, the United Kingdom, Switzerland and Korea, 6
exhibitors from the USA, 16 exhibitors from Taiwan China, as well as
other overseas exhibitors from Denmark, Germany, France, Japan, India,
Singapore, Canada, among others.
Exhibitors include a wide range of companies, such as Sinopeg Biotech,
novoprotein, Genloci Biotechnologies, GenScript, Canaan Pharmaceutical
Equipment, MD Biosciences, Valin Technologies, Bio-Chem Engineering,
Meissner Filtraton, Life Sciences Advanced Technologies, Stoel Rives,
Springer, etc.
Chinese exhibitors are mainly from bio medicine industrial bases among
which Nanjing Biopharmaceutical Valley (NJBV) is being highlighted. The
State-level Biomedical Science and Technology Incubator is on the
leading place in terms of booth space and exhibitor rankings, indicating
itself as a dynamic biopharmaceutical industrial base. More than 30
firms and research institutes will present a live showcase of
cutting-edge technology and sophisticated equipments by bio
pharmaceutical industry in Nanjing.
Overseas companies will meet Nanjing Biopharmaceutical Valley on site,
besides attending the fair, you will get a great chance for investment
in Nanjing.
NJBV is located in the State-level Nanjing High-Tech Zone, the northwest
of the city, adjacent to the north shore of Yangtze River. Nanjing
Biopharmaceutical Valley aims to become the biopharmaceutical industrial
base and high-end biopharmaceutical research area according to the
industrial layout set by Nanjing City Committee of the CPC and the
municipal Government. Currently, there are around 150 bio-pharmaceutical
enterprises in NJBV, covering the fields of chemical medicine,
bio-medicine, diagnostic reagents, medical instruments, Chinese
traditional medicine, and R&D outsourcing service, and etc. In 2012, the
business income of biopharmaceutical industry achieved around RMB 9.4
billion.
As a Biopharmaceutical Park, NJBV enjoys the greatest investment
potential, especially with distinct advantage at research achievement
transfer. State-level Biomedical Science and Technology Incubator is
located in the built-up area of Nanjing Biopharmaceutical Valley
covering an area of 65,000 m2. Currently, there are 21
leading biopharmaceutical enterprises and high-tech players in this area.
Nanjing Biopharmaceutical Valley Public Service Platform is designed to
meet enterprises demand, integrating resources in order to provide
various services on instruments, information, technology, and
investment. It strives to promote innovation capacities, enlarge the
scope of the industry, enhance competitiveness, and achieve the
sustainable development of the biopharmaceutical industry. The platform
will offer public services including Biopharmaceutical public instrument
analysis Service, Biopharmaceutical Public Information Service, Organic
Synthesis R&D Service, Pilot Scale Experiment Service, Investment and
Finance Service and Business Service.
More information about Nanjing City:
-
Scientific and Human Resource Advantages
Nanjing is
one of the four R&D and education centers in China, especially for its
top-ranking comprehensive biomedical R&D strength.
-
16 of the universities have Biopharmaceutical related majors, with
nearly 20,000 on-campus students
Nanjing University,
Southeast University, Nanjing University of Technology, China
Pharmaceutical University, Nanjing Medical University, Nanjing
University of Chinese Medicine, Nanjing Normal University, among
others.
-
67 Biomedical research institutes
Nanjing owns 6
national level research institutes, 57 provincial level research
institutes, and 4 municipal research institutes, such as National
biochemistry engineering research center, National Resource Center for
Mutant Mice and Jiangsu province Drug research institute
-
18 Authorities in the field of Biopharmaceutical
6
Academicians of China Academy of Science, 10 Academicians of China
Academy of Engineering, and 2 Masters of Traditional Chinese Medical
Science
-
Location Advantage
As a city in eastern China, it’s
adjacent to six provinces and one municipality, which altogether
account for one half of China’s economy scale.
In addition, it’s
located in Yangtze River delta and surrounded by Jiangsu Province,
which enjoys advantages at biopharmaceutical R&D.
Copyright Business Wire 2014